Exchange Bulletin

Replicel Life Sciences Inc. (RP) To Trade On Toronto Stock Exchange


January 13, 2014

REPLICEL LIFE SCIENCES INC. ("RP")
BULLETIN TYPE: New Listing-Shares
BULLETIN DATE: January 10, 2014
TSX Venture Tier 1 Company

Effective at the opening on Monday, January 13, 2014, the common shares of the Company will commence trading on TSX Venture Exchange. The Company is classified as a 'Life Sciences' company.

The Company is presently trading on the CNSX.

Corporate Jurisdiction: British Columbia

Capitalization: Unlimited common shares with no par value of which
48,118,609 common shares are issued and outstanding
Escrowed Shares: 23,508,682 common shares

Transfer Agent: Computershare Trust Company of Canada
Trading Symbol: RP
CUSIP Number: 76027P 10 3
Sponsoring Member: Canaccord Genuity Corp.

Company Contact: David Hall
Company Address: 2020 - 401 West Georgia St., Vancouver BC V6B 5A1
Company Phone Number: (604) 248-8730
Company Fax Number: (604) 248-8690
Company Email Address: info@replicel.com